Phreesia Target Price

Analysts' average 12-month price target for Phreesia is $13.

Get informed when a big investor buys or sells

+ Follow

Share Price

$10.15

Average Target Price

$12.57

23.9% upside

7 analysts in the last 4 months

High: $16 | Low: $10

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-09-04	D.A. Davidson	$13	28.1% upside
2026-09-04	Robert W. BairdJoe Vruwink	$11	8.4% upside
2026-09-03	Wells FargoStan Berenshteyn	$10	1.5% downside
2026-05-28	Piper SandlerJessica Tassan	$12	18.2% upside
2026-05-28	D.A. DavidsonClark Wright	$14	37.9% upside
2026-05-28	Truist FinancialJailendra Singh	$12	18.2% upside
2026-05-28	Canaccord Genuity	$16	57.6% upside
2026-05-20	Wells FargoStan Berenshteyn	$9	11.3% downside
2026-05-14	Barclays	$10	1.5% downside
2026-02-04	Mizuho SecuritiesSteven Valiquette	$22	116.7% upside
2026-01-23	D.A. Davidson	$30	195.6% upside
2026-01-08	Wells FargoStan Berenshteyn	$30	195.6% upside
2026-01-08	Truist Financial	$24	136.5% upside
2025-12-16	Barclays	$24	136.5% upside
2025-12-10	Truist Financial	$29	185.7% upside
2025-12-10	Mizuho SecuritiesSteven Valiquette	$28	175.9% upside
2025-12-10	Robert W. Baird	$25	146.3% upside
2025-12-09	Canaccord GenuityRichard Close	$33	225.1% upside
2025-12-08	Barclays	$26	156.2% upside
2025-12-02	D.A. DavidsonClark Wright	$35	244.8% upside
2025-10-08	KeyBanc	$32	215.3% upside
2025-09-08	JMP SecuritiesAaron Kimson	$34	235% upside
2025-09-05	Truist Financial	$36	254.7% upside
2025-09-05	Raymond James	$33	225.1% upside
2025-09-05	D.A. Davidson	$33	225.1% upside
2025-09-05	Canaccord GenuityRichard Close	$38	274.4% upside
2024-12-11	Robert W. BairdJoe Vruwink	$30	195.6% upside
2024-11-29	D.A. DavidsonGil Luria	$32	215.3% upside
2024-09-06	Truist FinancialJailendra Singh	$31	205.4% upside
2024-09-06	Robert W. BairdJoe Vruwink	$34	235% upside
2024-09-05	Piper SandlerSean Wieland	$30	195.6% upside
2024-05-31	Canaccord GenuityRichard Close	$34	235% upside
2024-05-29	Truist FinancialJailendra Singh	$35	244.8% upside
2024-05-24	KeyBancScott Schoenhaus	$30	195.6% upside
2024-03-21	JMP SecuritiesAaron Kimson	$30	195.6% upside
2024-03-18	Robert W. BairdJoe Vruwink	$31	205.4% upside
2024-03-15	RBC CapitalSean Dodge	$23	126.6% upside
2023-12-06	NeedhamRyan MacDonald	$29	185.7% upside
2023-09-07	StephensJeff Garro	$37	264.5% upside
2023-01-04	NeedhamRyan MacDonald	$40	294.1% upside
2022-12-09	RBC Capital	$26	156.2% upside
2022-10-12	D.A. DavidsonRobert Simmons	$25	146.3% upside
2022-03-30	Robert W. BairdJoseph Vruwink	$51	402.5% upside
2022-03-30	Leerink PartnersStephanie Davis	$29	185.7% upside
2021-09-02	Cantor FitzgeraldSteven Halper	$70	589.7% upside
2021-07-12	KeyBancDonald Hooker	$73	619.2% upside
2021-06-08	Berenberg BankGal Munda	$70	589.7% upside

Phreesia (PHR) FAQ

Phreesia posts a target price of $13. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $13 for PHR means covering analysts, on average, see the stock 23.9% upside of $10.15 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for PHR's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Phreesia's other metric pages and overview cover the third.

Judging Phreesia against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in target price easier to interpret. Start with $13 here, then scan peer and history charts to see if the gap is persistent.